Monthly Newsletter

Get the latest information about cancer care and research at MSK every month.

Newsletter Sign Up Manage Preferences

November 2016

How MSK pioneered a breakthrough treatment for pediatric cancer, plus lung cancer awareness and easy ways to fundraise.
View current issue now »


Back Issues

  • October 2016
    What we’re leanring from immunotherapy, the facts about bone marrow donation, and how to care for a caregiver.
  • September 2016
    Meet our new pediatrics chief, see the impact of our Humans of New York coverage, and test your knowledge of gynecologic cancer.
  • August 2016
    Celebrating our 27th year as one of the nation’s top two cancer centers, avoiding chemotherapy if you have early-stage breast cancer, myths and truths about chemotherapy.
  • July 2016
    News for men with metastatic prostate cancer, advances in sarcoma diagnosis and treatment, and summer travel tips for people in active treatment.
  • June 2016
    Invitation to a livestream of Vice President Biden’s first national Cancer Moonshot initiative summit conversation, MSK patients express LGBT pride, and news of a key AML discovery.
  • May 2016
    Vice President Biden leads a brainstorming session on the national Cancer Moonshot initiative at MSK, the FDA approves two immunotherapy drug combinations, and Humans of New York highlights our pediatrics department.
  • April 2016
    The Parker Institute for Cancer Immunotherapy launches, watchful waiting with lymphoma, and highlights from the American Association for Cancer Research meeting.
  • March 2016
    MSK’s Teen and Young Adult Program begins, how to spare normal tissue when manipulating the immune system to fight cancer, and news of a surprising novel treatment for venous malformation.
  • February 2016
    Celebrating nursing excellence at MSK, tips on searching for reliable cancer information online, and what to expect at the new Josie Robertson Surgery Center.
  • January 2016
    President Obama’s “moonshot” to cure cancer, ovarian cancer screening for average-risk women, and convincing reasons to abstain from alcohol if you have liver cancer.